Literature DB >> 10365089

The E-cadherin/epidermal growth factor receptor interaction: a hypothesis of reciprocal and reversible control of intercellular adhesion and cell proliferation.

A U Jawhari, M J Farthing, M Pignatelli.   

Abstract

The E-cadherin/catenin complex is a calcium-dependent cell-cell adhesion molecule, whose function is critical to the integrity of the adherens junction and which plays a role in the establishment and maintenance of normal epithelial morphology and differentiation. Loss of E-cadherin-mediated adhesion appears to be a fundamental aspect of the neoplastic phenotype which in some cases appears to be mediated by post-translational modifications (i.e. tyrosine phosphorylation) of its interacting proteins, the catenins which link E-cadherin to the actin cytoskeleton. There is increasing experimental evidence to suggest that epidermal growth factor receptor tyrosine phosphorylation may lead to the inactivation of the E-cadherin/catenin complex in cancer cells through its interaction with beta- or gamma-catenin in the cytoskeleton. Modulation of epidermal growth factor receptor activity by pharmacological agents has the potential to regulate a variety of cellular processes including adhesion, differentiation, and proliferation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10365089     DOI: 10.1002/(SICI)1096-9896(199901)187:2<155::AID-PATH193>3.0.CO;2-E

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

Review 1.  Patterning of cell assemblies regulated by adhesion receptors of the cadherin superfamily.

Authors:  M Takeichi; S Nakagawa; S Aono; T Usui; T Uemura
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-07-29       Impact factor: 6.237

Review 2.  The role of the E-cadherin complex in gastrointestinal cell differentiation.

Authors:  R Del Buono; M Pignatelli
Journal:  Cell Prolif       Date:  1999 Apr-Jun       Impact factor: 6.831

3.  Beta-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: relationships with carcinogenesis and metastasis.

Authors:  Yu-Jun Li; Zhi-Min Wei; Yun-Xiao Meng; Xiang-Rui Ji
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

4.  Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.

Authors:  Jacqueline Jones; Honghe Wang; Jianjun Zhou; Shana Hardy; Timothy Turner; David Austin; Qinghua He; Alan Wells; William E Grizzle; Clayton Yates
Journal:  Am J Pathol       Date:  2012-09-10       Impact factor: 4.307

Review 5.  Molecular histology in the study of solid tumours.

Authors:  R J Campbell; M Pignatelli
Journal:  Mol Pathol       Date:  2002-04

Review 6.  EGFR may couple moderate alcohol consumption to increased breast cancer risk.

Authors:  Christopher P Mill; Julia A Chester; David J Riese
Journal:  Breast Cancer (Dove Med Press)       Date:  2009-10-05

7.  Effects of HER2 overexpression on cell signaling networks governing proliferation and migration.

Authors:  Alejandro Wolf-Yadlin; Neil Kumar; Yi Zhang; Sampsa Hautaniemi; Muhammad Zaman; Hyung-Do Kim; Viara Grantcharova; Douglas A Lauffenburger; Forest M White
Journal:  Mol Syst Biol       Date:  2006-10-03       Impact factor: 11.429

8.  Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline.

Authors:  C Yates; A Wells; T Turner
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

9.  Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin.

Authors:  C C Yates; C R Shepard; D B Stolz; A Wells
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

10.  Zinc Status Impacts the Epidermal Growth Factor Receptor and Downstream Protein Expression in A549 Cells.

Authors:  Emily Scheiermann; Mary-Ann Puppa; Lothar Rink; Inga Wessels
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.